Since the half-life of most angiogenic growth factors is several hours or less, sustained-release delivery would be optimal for their future clinical use. Two fibroblast growth factors, basic fibroblast growth factor (bFGF) and endothelial cell growth factor (ECGF), were delivered in two sustained-released modalities (poloxamer 407 and a gelatin sponge [Gelfoam]) to attempt to increase soft tissue vascularity. In vitro bioactivity of ECGF-poloxamer formulations was also tested on endothelial cell cultures. Among vascular-compromised skin flaps in rabbits, ECGF-poloxamer (N = 26), bFGF-poloxamer (N = 5), ECGF-poloxamer (N = 9, irradiated), and bFGF-Gelfoam flaps (N = 22) did not demonstrate significant differences in viability and vascularity compared to controls (p > .05). Irradiation had a detrimental effect on both flap vascularity and viability (p = .02). Future efforts for sustained delivery of angiogenic proteins are critical in order to make them clinically useful in wound healing.
Klein-SoyerCBeretzACazenaveJPDriotFMaffrandJ. Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor. Biol Cell1990; 68: 231–8.
ThompsonJAAndersonKADiPietroJM. Site-directed neovessel formation in vivo. Science1988; 241: 1349–52.
4.
HaywardPGAlisonWECarpSSHuiPSRobsonMC. Local infiltration of an angiogenic growth factor does not stimulate the delay phenomenon. Br J Plast Surg1991; 44: 526–9.
5.
ImMJKimYSEdwardsRJHoopesJEFenselauA. The effect of bovine basic fibroblast growth factor on skin flap survival in rats. Ann Plast Surg1992; 28: 242–5.
6.
IshiguroNYabeYShimizuTIwataHMiuraT. Basic fibroblast growth factor has a beneficial effect on the viability of random skin flaps in rats. Ann Plast Surg1994; 32: 356–60.
7.
KhouriRKBrownDMLeal-KhouriSMTarkKCShawWW. The effect of basic fibroblast growth factor on the neovascularization process: Skin flap survival and staged flap transfers. Br J Plast Surg1991; 44: 585–8.
8.
UhlEBarkerJHBondarIGallaTJLehrHAMessmerK. Improvement of skin flap perfusion by subdermal injection of recombinant human basic fibroblast growth factor. Ann Plast Surg1994; 32: 361–5.
9.
JohnstonTPPunjabiMAFroelichCJ. Sustained delivery of interleukin-22 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm Res1992; 9: 421–30.
10.
FultsKAJohnstonTP. Sustained release of urease from a poloxamer gel matrix. J Parenter Sci Technol1990; 44: 558–65.
11.
JohnstonTPMillerSC. Toxicological evaluation of poloxamers for intramuscular use. J Parenter Sci Technol1985; 39: 83–8.
12.
PecEAWoutZJohnstonTP. Biological activity of urease formulated in poloxamer 407 following intraperitoneal injection in the rat. J Pharm Sci1992; 81: 626–30.
13.
TanELShahHSLeisterKJ. Transforming growth factor-α (TGF-α) in a semisolid dosage form: Preservative and vehicle selection. Pharm Res1993; 10: 1238–42.
14.
RifkinDBMoscatelliD. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol1989; 109: 1–6.
15.
SchreiberAKenneyJKowalskiWFrieselRMehlmanTMacIagT. Interaction of endothelial cell growth factor with heparin: Characterization by receptor and antibody recognition. Proc Natl Acad Sci U S A1985; 82: 6138–42.
16.
GospodarowiczDChenyJ. Heparin protects basic and acid FGF from inactivation. J Cell Physiol1986; 128: 475–84.
17.
HornDBAssefaG. Effects of endothelial cell growth factor on vascular compromised skin flaps. Arch Otolaryngol Head Neck Surg1992; 118: 624–8.
18.
DimitrievichGSFischer-DzogaKGriemM. Radiosensitivity of vascular tissue. I. Differential radiosensitivity of capillaries: A quantitative in vivo study. Radiat Res1984; 99: 511–35.
19.
PattersonTJBerryRJHopewellJWWiernekG. The effect of radiation in survival of experimental skin flaps. In: GrabbWCMyersMB, eds. Skin flaps. Boston, Mass: Little, Brown, 1975: 39–46.
20.
ErolOSpiraMLevyB. Microangiography: A detailed technique of perfusion. J Surg Res1980; 29: 406–13.
21.
FriedMHorowitzZKellyJStromeM. The importance of the pedicle for the survival of a vascularized free flap: An experimental study on rats. Head Neck Surg1982; 5: 130–3.
22.
KlingbeilCKCesarLBFiddesJC. Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. Prog Clin Biol Res1991; 365: 443–58.
23.
LobbRRAldermanEMFettHW. Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor. Biochemistry1985; 24: 4969–73.
24.
WangPJohnstonTP. Thermal-induced denaturation of two model proteins: Effect of poloxamer 407 on solution stability. Int J Pharm1993; 96: 41–9.
25.
WangPJohnstonTP. Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407. J Parenter Sci Technol1993; 47: 183–9.
26.
HornDBakerSGrahamLMMcClatcheyKD. Utilizing angiogenic agents to expedite the neovascularization process in skin flaps. Laryngoscope1988; 98: 521–6.
27.
MatuszewskaBKeoganMFisherDM. Acidic fibroblast growth factor: Evaluation of topical formulations in a diabetic mouse wound healing model. Pharm Res1994; 11: 65–71.
28.
KleimanLAHasslingerBEddyHSuterCBlanchardCGrayW. The effects of carbocisplatinum and radiation on skin flap survival. Arch Otolaryngol1992; 118: 68–73.
29.
NemiroffPMMerwinGEBrantTCassisiNJ. Effects of hyperbaric oxygen and irradiation on experimental skin flaps in rats. Otolaryngol Head Neck Surg1985; 93: 485–91.
30.
WeismanRABlumbergALBrousseauDAHarfordWESilvermanDG. Fluorometric assessment of skin flap viability in the rat: Effect of radiation therapy. Otolaryngol Head Neck Surg1983; 91: 151–5.
31.
DownsECRobertsonNERissTPlunkettML. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol1992; 152: 422–9.
32.
YerushalmiNAradAMargalitR. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. ArchBiochem Biophys1994; 313: 267–73.
33.
RoyFDeBloisCDoillonCJ. Extracellular matrix analogs as carriers for growth factors: In vitro fibroblast behavior. J Biomed Mater Res1993; 27: 389–97.
34.
LangerR. Delivery systems for angiogenesis stimulators and inhibitors. EXS1992; 61: 327–30.
35.
AndersonPMHansonDCHaszDEHaletMRBlazarBROchoaAC. Cytokines in liposomes: Preliminary studies with IL-1, IL-2, IL-6, GM-DSF and interferon-gamma. Cytokine1994; 6: 92–101.
36.
LangerRMosesM. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem1991; 45: 340–5.
